Longevity Foundation

The Longevity Foundation stack addresses three fundamental pillars of biological aging: telomere attrition, extracellular matrix degradation, and immune senescence. Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It activates telomerase — the enzyme that rebuilds telomere caps on chromosomes — in somatic cells. In Khavinson''s clinical studies, Epithalon administration to elderly patients was associated with reduced mortality, improved immune markers, and normalization of melatonin production from the pineal gland. It is administered in 10-day cycles, typically twice per year. GHK-Cu is a naturally occurring copper-binding tripeptide that functions as a master regulator of tissue remodeling. Beyond its surface-level skin benefits, GHK-Cu modulates the expression of over 4,000 genes — many involved in DNA repair, antioxidant production (SOD, glutathione), stem cell proliferation, and suppression of pro-inflammatory cytokines. Its concentration in human plasma drops from 200 ng/mL at age 20 to 80 ng/mL by age 60, correlating with visible aging and reduced regenerative capacity. Thymosin Alpha-1 addresses immunosenescence — the progressive decline of immune function with age that increases susceptibility to infections, cancer, and autoimmune conditions. By promoting T-cell maturation, dendritic cell activation, and natural killer cell function, Ta1 helps restore immune surveillance to more youthful levels. The three-peptide combination creates a comprehensive anti-aging protocol: Epithalon maintains chromosomal integrity, GHK-Cu restores tissue remodeling capacity and gene expression patterns, and Thymosin Alpha-1 rejuvenates immune competence. This represents a systems-biology approach to aging rather than targeting any single pathway.